Navigation Links
Raven Announces Continued Enrollment of Phase 1/2a Clinical Trial of RAV12 Therapeutic Antibody for Treatment of Adenocarcinomas
Date:11/27/2007

SOUTH SAN FRANCISCO, Calif., Nov. 27 /PRNewswire/ -- Raven biotechnologies, inc., a privately held company focused on the development of monoclonal antibody therapeutics (MAbs) for cancer, today announced it is continuing to enroll new patients in the maximum tolerated dose cohort expansion segment of its Phase 1/2a trial for patients with cancers of the gastrointestinal tract that express the RAAG12 antigen.

RAAG12 is a glycotope (sugar structure) that is widely found on the surface of tumor cells of many kinds of cancer, particularly cancers of the gastrointestinal tract (adenocarcinomas of gastroesophageal, pancreatic and colorectal origin). RAV12, Raven's lead clinical monoclonal antibody drug candidate, targets the RAAG12 antigen.

This segment of the trial will yield additional information about the safety of the drug and define the pharmacokinetics of the antibody.

The appropriate dose and schedule of RAV12 was chosen in a dose-escalation segment of the Phase 1/2a trial that involved 33 patients. This trial revealed that a fractionated dosing regimen provided an improved safety profile for the antibody. Raven is now enrolling patients in a second segment of the trial in which all patients are receiving the recommended dose and schedule of drug. Information from the Phase 1/2a trial will be supporting the dosing in a Phase 2 study in pancreatic cancer, the next clinical trial scheduled for RAV12.

The trial is being conducted at five institutions in the United States: The Sarah Cannon Cancer Center in Nashville, TN; The Fox Chase Cancer Center in Philadelphia, PA; Premiere Oncology in Santa Monica, CA; Georgetown University Medical Center in Washington, DC; and The University of Miami Medical Center in Miami, FL.

About RAV12

RAV12 is a novel, chimeric monoclonal antibody that is directed against a primate-specific glycotope (sugar structure) that is widely displayed on the surfaces of tumor cells, particularly tho
'/>"/>

SOURCE Raven biotechnologies, inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Cadence Pharmaceuticals Completes Enrollment of Pivotal Phase III Trial for Intravenous Acetaminophen Ahead of Schedule
2. Raven Announces Phase 1 Clinical Trial Results of RAV12 Therapeutic Antibody for Treatment of Adenocarcinomas
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
7. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
8. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
9. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
10. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
11. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... 17, 2013  Lakeland Industries, Inc. (NASDAQ: ... for industry, healthcare and to first responders on the ... results for the fiscal 2013 fourth quarter and year ... at stock market close and will conduct a conference ... (Logo: http://photos.prnewswire.com/prnh/20120611/NY21959LOGO ) ...
(Date:5/17/2013)... , May 17, 2013  Technology advances have ... internally. Faced with a constantly evolving communication environment, ... tactics for communicating with internal executives. It is ... the strategies, tactics and tools that are part ... a new study, Best Practices, LLC explores the ...
(Date:5/17/2013)... 2013  Sony Biotechnology Inc. ("Sony") today announced the ...  Sony will be exhibiting and taking orders for this ... the San Diego Convention Center ... May 20 - 22.  The SP6800 ... audio-visual technologies into new and novel functionalities for the ...
Breaking Medicine Technology:Lakeland Industries to Report Fiscal Fourth Quarter and Year End Financial Results and Conduct Conference Call 2Internal Communication Strategies and Tactics that Resonate with Key Stakeholders and Drive Organizational Effectiveness 2Sony Biotechnology Inc.'s New Technology for Science Provides Researchers Results in Color 2
... Pa., Nov. 17, 2010 Offering another suggestion to ... said today that the commonwealth could save millions of ... Pennsylvania state government spends more than $2 ... million Pennsylvanians, through 17 drug programs overseen by nine ...
... Pa., Nov. 17, 2010 Environmental Tectonics Corporation,s (OTC ... "Company") Sterilization Systems Group announced today that it has ... for three industrial Ethylene Oxide (EtO) Sterilization Systems.   ... to a major multi-national corporation, include material handling systems, ...
Cached Medicine Technology:Auditor General Jack Wagner Says State Could Save Millions by Consolidating Prescription Drug Purchases 2Auditor General Jack Wagner Says State Could Save Millions by Consolidating Prescription Drug Purchases 3Environmental Tectonics Corporation's Sterilization Systems Group Awarded Major Contract 2Environmental Tectonics Corporation's Sterilization Systems Group Awarded Major Contract 3Environmental Tectonics Corporation's Sterilization Systems Group Awarded Major Contract 4
(Date:5/19/2013)... May 20, 2013 The three surgeons ... Medical Group: David A. Abrutyn, M.D., Robert S. Boretz, ... see patients at their current location, 215 Union Avenue, ... has expertise in sports medicine, with emphasis on injuries ... adolescent, and adult patients for a wide range of ...
(Date:5/19/2013)... Boise, Idaho (PRWEB) May 19, 2013 ... restless feet, may be put to an end through ... restless feet may be caused by a number of ... peripheral neuropathy. This is because peripheral neuropathy is characterized ... and these nerves are part of a larger system, ...
(Date:5/19/2013)... May is officially known as Skin Cancer Awareness ... Australia, the country's forerunner in fashionable children’s sun ... to kick off their month long mission to bring ... staggering number of cancer cases diagnosed each year, the ... out what’s causing the epidemic and how to stop ...
(Date:5/19/2013)... , , SATURDAY, May 18 (HealthDay News) -- Vitamin ... overcome the fatigue and decreased muscle strength associated ... research. Extra vitamin D "was associated with ... quality of life and the ability to perform ... research dietitian and doctoral candidate at Trinity College ...
(Date:5/19/2013)... May 19, 2013 According to a May ... many people are self-conscious about the appearance of certain areas ... when diet and exercise fail to tone and tighten these ... to those looking to get the firmest body possible ... effective mini-overview,” says Dr. Simon Ourian, Medical Director of Epione ...
Breaking Medicine News(10 mins):Health News:Summit Medical Group Welcomes the Center for Orthopedic Care 2Health News:Summit Medical Group Welcomes the Center for Orthopedic Care 3Health News:Peripheral Neuropathy Naturally Treatable Through Neuracel's Ultimate Neuropathy Support System 2Health News:Leading Children’s Sun Protection Swimwear Company Platypus Australia use Skin Cancer Awareness Month to Help Educate Parents 2Health News:Leading Children’s Sun Protection Swimwear Company Platypus Australia use Skin Cancer Awareness Month to Help Educate Parents 3Health News:Extra Vitamin D May Ease Crohn's Symptoms, Study Finds 2Health News:Extra Vitamin D May Ease Crohn's Symptoms, Study Finds 3Health News:Body Firming – The Hottest Treatments Available 2
... ... Underwriter Enhances Innovative Solutions for Travelers and Individuals , ... Indianapolis, IN (PRWEB) August 10, ... health insurance, today announced it has signed an agreement with Eldorado Computing, Inc. ...
... ... ... -- Tucson, Arizona is home to a dense Hispanic population. In recognition of September ... the word throughout the local Hispanic community that colorectal pre-screening can save lives., , ...
... cancer can preserve future fertility by keeping at least one ovary ... disease. The study is published in the September 15, 2009 issue ... Society. Most cases of ovarian cancer are diagnosed at later ... ovarian tumors occur in women 40 years of age or younger, ...
... Ultherapy ... more lifted and contoured face? This breakthrough in non-surgical facelift actually delivers all that ... ... of non-surgical facelift. This breakthrough device has the potential to upend the non-surgical facial ...
... ... The 2009 J-1/H-1B Foreign Physician Immigration Conference and Job Fair Series includes ... Baltimore on Oct. 24. The annual series is free and provides ... medical training in the U.S. and residency program directors and coordinators, who ...
... perspective, it may be more efficient to use the drug ... wild-type KRAS gene, according to a study published online August ... . Earlier, patients whose tumors harbored wild-type KRAS were ... cetuximab in a randomized trial by the National Cancer Institute ...
Cached Medicine News:Health News:HCC Medical Insurance Services Selects Eldorado's Innovative Claims & Benefits Platform 2Health News:Hispanics at High Risk for Colorectal Cancer 2Health News:Hispanics at High Risk for Colorectal Cancer 3Health News:Young early stage ovarian cancer patients can preserve fertility 2Health News:The Sloane Clinic pioneers Ultherapy in Singapore 2Health News:The Sloane Clinic pioneers Ultherapy in Singapore 3Health News:14th Annual J-1/H-1B Foreign Physician Immigration Conference and Job Fair Series Kicks-Off in New York City 2Health News:14th Annual J-1/H-1B Foreign Physician Immigration Conference and Job Fair Series Kicks-Off in New York City 3Health News:Cost-effectiveness of cetuximab in metastatic colorectal cancer 2
... The DryEase Mini-Gel Drying System is a simple ... evaporation. The kit allows gels to be assembled ... both outer surfaces of the gels are exposed ... is minimized. The proprietary Gel-Dry™ Drying Solution modulates ...
... generations. Most gels can be dried by positioning ... gel dryer, covering them with wet semi-permeable cellophane ... the cellophane flat. Tut's Tombs also produce great ... somewhat larger than the gel to be dried. ...
... Preserve your data for future generations. Most ... the solid backing plate of our gel dryer, ... a frame over them to hold the cellophane ... a frame with an open area somewhat larger ...
Each GelAir™ system drying frame includes two main components, a plastic drying outer frame and a metal square inner frame, as well as 8 clamps per frame. Supplied as a set of two frames....
Medicine Products: